4-bromobutyl phenyl sulfone | 5755-78-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-bromobutyl phenyl sulfone
• 英文别名: ((4-bromobutyl)sulfonyl)benzene；4-Phenylsulfonylbutyl bromide；4-bromobutylsulfonylbenzene
• CAS: 5755-78-2
• 化学式: C₁₀H₁₃BrO₂S
• 分子量: 277.182
• InChiKey: JXPXIYVBJNQZFQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-bromobutyl phenyl sulfone 在 sodium iodide 作用下， 以 丙酮 为溶剂， 反应 36.0h， 生成 (cyclobutylsulfonyl)benzene
  参考文献：
  名称：

  Decesare, John M.; Corbel, Bernard; Durst, Tony, Canadian Journal of Chemistry, 1981, vol. 59, p. 1415 - 1424

  摘要：

  DOI：
• 作为产物：
  描述：

  4-苯磺酰基乙酸丁酯 在 硫酸 、 氢溴酸 作用下， 反应 16.0h， 以13.3 g的产率得到4-bromobutyl phenyl sulfone
  参考文献：
  名称：

  Monteiro, Hugo J.; Stefani, Helio A., European Journal of Organic Chemistry, 2001, # 14, p. 2659 - 2663

  摘要：

  DOI：

文献信息

• Quaternary Ammonium Trifluoromethoxide Salts as Stable Sources of Nucleophilic OCF₃
  作者：Josiah J. Newton、Benson J. Jelier、Michael Meanwell、Rainer E. Martin、Robert Britton、Chadron M. Friesen

  DOI：10.1021/acs.orglett.0c00099

  日期：2020.3.6

  methyl ethers provides quaternary ammonium trifluoromethoxide (NR4OCF3) and pentafluoroethoxide (NR4OCF2CF3) salts, respectively, in good yields. The new trifluoromethoxide salts disclosed herein are uniquely stable for extended periods of time in both the solid state and in solution, which complements contemporary reagents. Here we describe the preparation of a range of NR4OCF3 salts, their long-term stability

  亲核叔胺与三氟甲基和五氟乙基甲基醚的反应分别以高收率提供了三氟甲基季铵盐（NR4OCF3）和五氟乙氧基盐（NR4OCF2CF3）盐。本文公开的新的三氟甲醇盐在固态和在溶液中均在延长的时间内具有独特的稳定性，这是对现代试剂的补充。在这里，我们描述了一系列NR4OCF3盐的制备，它们的长期稳定性以及在取代反应中的效用。
• A new approach to cyclic hydroxamic acids: intramolecular cyclization of N-benzyloxy carbamates with carbon nucleophiles
  作者：Yuan Liu、Hollie K. Jacobs、Aravamudan S. Gopalan

  DOI：10.1016/j.tet.2011.01.073

  日期：2011.3

  moderate yields. The sulfone intermediates 3 from this study can be alkylated while the corresponding phosphonates have been shown to undergo HWE reaction. The α,β-unsaturated synthon, 8, prepared by thermal elimination of sulfoxide 3m, undergoes Michael addition with secondary amines. The usefulness of this approach to prepare polydentate chelators has been demonstrated by the synthesis of bis cyclic hydroxamic

  N-烷基-N-苄氧基氨基甲酸酯2与各种碳亲核试剂进行轻松的分子内环化，得到官能化的五元和六元受保护环状异羟肟酸3，收率良好至极好。该方法可以扩展到以中等产率制备七元环异羟肟酸。本研究中的砜中间体3可以被烷基化，而相应的膦酸酯已被证明可以进行 HWE 反应。α,β-不饱和合成子, 8 , 亚砜3m热消去制备, 与仲胺发生迈克尔加成。这种方法中，以制备多齿螯合剂的实用性已经通过双环状异羟肟酸的合成方法证实12，14，和15。
• Cardiotonic and antithrombotic sulfur-containing derivatives of
  申请人：Boehringer Ingelheim GmbH

  公开号：US04329347A1

  公开（公告）日：1982-05-11

  Compounds of the formula ##STR1## wherein W is vinylene, methyl-vinylene, methylene or ethylene; m is 0, 1 or 2; D is straight or branched alkylene of 2 to 6 carbon atoms, straight or branched hydroxy-alkylene of 3 to 6 carbon atoms, or xylylene; R.sub.1 is hydrogen or alkyl of 1 to 3 carbon atoms; R.sub.2 is cycloalkyl of 3 to 6 carbon atoms, aryl of 6 to 10 carbon atoms, aralkyl of 7 to 11 carbon atoms, heteroaryl, heteroarlkyl, 1,2,4-triazolyl, triphenylmethyl, 4,5-bis-(p-chlorophenyl)-oxazol-2-yl, N-methyl-cyclohexylamino-carbonylmethyl,-amino-iminomethyl or, when m is 1 or D is hydroxyalkylene or xylylene, also alkyl of 1 to 6 carbon atoms; and R.sub.3 and R.sub.4 are each hydrogen, halogen, alkyl of 1 to 4 carbon atoms, amino, acetylamino or nitro. The compounds of the invention are useful as cardiotonics and as antithrombotics.

  式为##STR1##的化合物，其中W为乙烯基、甲基乙烯基、亚甲基或乙烯基；m为0、1或2；D为2至6个碳原子的直链或支链烷基、3至6个碳原子的直链或支链羟基烷基，或二甲苯基；R.sub.1为氢或1至3个碳原子的烷基；R.sub.2为3至6个碳原子的环烷基、6至10个碳原子的芳基、7至11个碳原子的芳基烷基、杂环芳基、杂环芳基烷基、1,2,4-三唑基、三苯甲基、4,5-双-(对氯苯基)-噁唑-2-基、N-甲基环己基氨基甲酰甲基、氨基亚甲基或当m为1或D为羟基烷基或二甲苯基时，也为1至6个碳原子的烷基；以及R.sub.3和R.sub.4分别为氢、卤素、1至4个碳原子的烷基、氨基、乙酰氨基或硝基。本发明的化合物可用作心力衰竭药和抗血栓药。
• Sulfone derivatives as 5-HT7 receptor ligands
  申请人：——

  公开号：US20040229864A1

  公开（公告）日：2004-11-18

  The present invention relates to sulfone derivatives of formula (I): Ar—SO 2 —CR 2 R 3 -L-N(R 1 ) 2 I wherein Ar, L, R 1 , R 2 and R 3 are as defined herein, and pharmaceutically acceptable salts and N-oxides thereof, useful in the treatment of a condition which is susceptible to treatment by modulation of 5-HT 7 receptor activity, such as depression or a sleep disorder.

  本发明涉及式（I）的砜衍生物：Ar—SO2—CR2R3-L-N(R1)2I，其中Ar，L，R1，R2和R3如本文所定义，并且其药用盐和N-氧化物，用于治疗通过调节5-HT7受体活性可治疗的疾病，如抑郁症或睡眠障碍。
• Benzoic acid compounds and use thereof as medicaments
  申请人：Yoshitomi Pharmaceutical Industries, Ltd.

  公开号：US05864039A1

  公开（公告）日：1999-01-26

  Benzoic acid compounds of the formula ##STR1## wherein each symbol is as defined in the specification, optical isomers thereof and pharmaceutically acceptable salts thereof; pharmaceutical composition comprising this compound and pharmaceutically acceptable additive; and serotonin 4 receptor agonists, gastrointestinal prokinetic agents and therapeutic agents for various gastrointestinal diseases, which comprise this compound as active ingredient. The compounds of the present invention have high and selective affinity for serotonin 4 receptor, and show agonistic effects thereon. Accordingly, they are useful medications for the prophylaxis and treatment of various gastrointestinal diseases, central nervous disorders, cardiac function disorders, urinary diseases, and the like, as well as useful anti-nociceptors for analgesic use which increase threshold of pain.

  苯甲酸化合物的化学式为##STR1##，其中每个符号如规范中定义，其光学异构体及其药用可接受盐；包括该化合物和药用可接受添加剂的药物组合物；以及将该化合物作为活性成分的5-羟色胺4受体激动剂、胃肠促动力剂和用于各种胃肠疾病的治疗剂。本发明的化合物具有对5-羟色胺4受体的高度和选择性亲和力，并显示出激动效应。因此，它们可用于预防和治疗各种胃肠疾病、中枢神经障碍、心脏功能障碍、泌尿系统疾病等，同时还可用作提高疼痛阈值的镇痛用途的有用抗痛觉剂。